These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 24677604)

  • 1. D-cycloserine for treating anxiety disorders: making good exposures better and bad exposures worse.
    Hofmann SG
    Depress Anxiety; 2014 Mar; 31(3):175-7. PubMed ID: 24677604
    [No Abstract]   [Full Text] [Related]  

  • 2. Lessons learned from D-cycloserine: the promise and limits of drug facilitation of exposure therapy.
    Rodebaugh TL; Lenze EJ
    J Clin Psychiatry; 2013 Apr; 74(4):415-6. PubMed ID: 23656850
    [No Abstract]   [Full Text] [Related]  

  • 3. D-cycloserine nasal formulation development for anxiety disorders by using polymeric gels.
    Shin Y; Kokate R; Desai V; Bhushan A; Kaushal G
    Drug Discov Ther; 2018; 12(3):142-153. PubMed ID: 29998995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Learn to forget: Does post-exposure administration of d-cycloserine enhance fear extinction in agoraphobia?
    Pyrkosch L; Mumm J; Alt I; Fehm L; Fydrich T; Plag J; Ströhle A
    J Psychiatr Res; 2018 Oct; 105():153-163. PubMed ID: 30237105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in Dosing and Dose Timing of D-Cycloserine Explain Its Apparent Declining Efficacy for Augmenting Exposure Therapy for Anxiety-related Disorders: An Individual Participant-data Meta-analysis.
    Rosenfield D; Smits JAJ; Hofmann SG; Mataix-Cols D; de la Cruz LF; Andersson E; Rück C; Monzani B; Pérez-Vigil A; Frumento P; Davis M; de Kleine RA; Difede J; Dunlop BW; Farrell LJ; Geller D; Gerardi M; Guastella AJ; Hendriks GJ; Kushner MG; Lee FS; Lenze EJ; Levinson CA; McConnell H; Plag J; Pollack MH; Ressler KJ; Rodebaugh TL; Rothbaum BO; Storch EA; Ströhle A; Tart CD; Tolin DF; van Minnen A; Waters AM; Weems CF; Wilhelm S; Wyka K; Altemus M; Anderson P; Cukor J; Finck C; Geffken GR; Golfels F; Goodman WK; Gutner CA; Heyman I; Jovanovic T; Lewin AB; McNamara JP; Murphy TK; Norrholm S; Thuras P; Turner C; Otto MW
    J Anxiety Disord; 2019 Dec; 68():102149. PubMed ID: 31698111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical parameters for D-cycloserine enhancement of cognitive-behaviorial therapy for obsessive-compulsive disorder.
    Rothbaum BO
    Am J Psychiatry; 2008 Mar; 165(3):293-6. PubMed ID: 18316423
    [No Abstract]   [Full Text] [Related]  

  • 7. D-Cycloserine Augmentation of Exposure-Based Cognitive Behavior Therapy for Anxiety, Obsessive-Compulsive, and Posttraumatic Stress Disorders: A Systematic Review and Meta-analysis of Individual Participant Data.
    Mataix-Cols D; Fernández de la Cruz L; Monzani B; Rosenfield D; Andersson E; Pérez-Vigil A; Frumento P; de Kleine RA; Difede J; Dunlop BW; Farrell LJ; Geller D; Gerardi M; Guastella AJ; Hofmann SG; Hendriks GJ; Kushner MG; Lee FS; Lenze EJ; Levinson CA; McConnell H; Otto MW; Plag J; Pollack MH; Ressler KJ; Rodebaugh TL; Rothbaum BO; Scheeringa MS; Siewert-Siegmund A; Smits JAJ; Storch EA; Ströhle A; Tart CD; Tolin DF; van Minnen A; Waters AM; Weems CF; Wilhelm S; Wyka K; Davis M; Rück C; ; Altemus M; Anderson P; Cukor J; Finck C; Geffken GR; Golfels F; Goodman WK; Gutner C; Heyman I; Jovanovic T; Lewin AB; McNamara JP; Murphy TK; Norrholm S; Thuras P
    JAMA Psychiatry; 2017 May; 74(5):501-510. PubMed ID: 28122091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opposing effects of D-cycloserine on fear despite a common extinction duration: interactions between brain regions and behavior.
    Bolkan SS; Lattal KM
    Neurobiol Learn Mem; 2014 Sep; 113():25-34. PubMed ID: 24374132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. D-cycloserine as an augmentation strategy for cognitive behavioral therapy for anxiety disorders: an update.
    Hofmann SG; Sawyer AT; Asnaani A
    Curr Pharm Des; 2012; 18(35):5659-62. PubMed ID: 22632472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A meta-analysis of D-cycloserine and the facilitation of fear extinction and exposure therapy.
    Norberg MM; Krystal JH; Tolin DF
    Biol Psychiatry; 2008 Jun; 63(12):1118-26. PubMed ID: 18313643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancing prolonged exposure therapy for posttraumatic stress disorder with D-cycloserine: further support for treatments that promote experience-dependent neuroplasticity.
    Krystal JH
    Biol Psychiatry; 2012 Jun; 71(11):932-4. PubMed ID: 22579302
    [No Abstract]   [Full Text] [Related]  

  • 12. Augmentation of exposure therapy with D-cycloserine for social anxiety disorder.
    Hofmann SG; Meuret AE; Smits JA; Simon NM; Pollack MH; Eisenmenger K; Shiekh M; Otto MW
    Arch Gen Psychiatry; 2006 Mar; 63(3):298-304. PubMed ID: 16520435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose Timing of D-Cycloserine to Augment Exposure Therapy for Social Anxiety Disorder: A Randomized Clinical Trial.
    Smits JAJ; Pollack MH; Rosenfield D; Otto MW; Dowd S; Carpenter J; Dutcher CD; Lewis EM; Witcraft SM; Papini S; Curtiss J; Andrews L; Kind S; Conroy K; Hofmann SG
    JAMA Netw Open; 2020 Jun; 3(6):e206777. PubMed ID: 32496566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Augmentation of behavior therapy with D-cycloserine for obsessive-compulsive disorder.
    Wilhelm S; Buhlmann U; Tolin DF; Meunier SA; Pearlson GD; Reese HE; Cannistraro P; Jenike MA; Rauch SL
    Am J Psychiatry; 2008 Mar; 165(3):335-41; quiz 409. PubMed ID: 18245177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. D-cycloserine augmentation of behavior therapy for anxiety and obsessive-compulsive disorders: A meta-analysis.
    Bürkner PC; Bittner N; Holling H; Buhlmann U
    PLoS One; 2017; 12(3):e0173660. PubMed ID: 28282427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D-Cycloserine lowers kynurenic acid formation--new mechanism of action.
    Baran H; Kepplinger B
    Eur Neuropsychopharmacol; 2014 Apr; 24(4):639-44. PubMed ID: 24189377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized placebo-controlled trial of D-cycloserine to enhance exposure therapy for posttraumatic stress disorder.
    de Kleine RA; Hendriks GJ; Kusters WJ; Broekman TG; van Minnen A
    Biol Psychiatry; 2012 Jun; 71(11):962-8. PubMed ID: 22480663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological enhancement of behavioral therapy: focus on posttraumatic stress disorder.
    Choi DC; Rothbaum BO; Gerardi M; Ressler KJ
    Curr Top Behav Neurosci; 2010; 2():279-99. PubMed ID: 21309114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurocognitive processes in d-cycloserine augmented single-session exposure therapy for anxiety: A randomized placebo-controlled trial.
    Reinecke A; Nickless A; Browning M; Harmer CJ
    Behav Res Ther; 2020 Jun; 129():103607. PubMed ID: 32229324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. d-Cycloserine does not enhance the effects of in vivo exposure among young people with broad-based anxiety disorders.
    Rapee RM; Jones MP; Hudson JL; Malhi GS; Lyneham HJ; Schneider SC
    Behav Res Ther; 2016 Dec; 87():225-231. PubMed ID: 27771572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.